ArticleContemporary oncology (Poznan, Poland)2022
Cluster analysis of deterioration sites after first-line epidermal growth factor receptor-tyrosine kinase inhibitor in epidermal growth factor receptor mutated non-small cell lung cancer.
Shinichiro Okauchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.